Transfusion of platelets containing ABO-incompatible plasma: A survey of 3156 North American Laboratories

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 6, 2007, Pages 909-916

  Fung, Mark K ^a   Downes, Katharine A ^b   Shulman, Ira A ^c  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY;

ACUTE LEUKEMIA; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR SURGERY; CLINICAL PRACTICE; CONSENSUS; HOSPITAL POLICY; HUMAN; PLASMA; THROMBOCYTE TRANSFUSION;

ABO BLOOD-GROUP SYSTEM; BLOOD BANKS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; HEMOLYSIS; HUMANS; NORTH AMERICA; PLATELET TRANSFUSION; QUESTIONNAIRES;

EID: 34250206997     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Blood transfusion practice. In: Brecher ME, ed. Technical Manual. 15th ed. Bethesda, Md: AABB; 2005:490-491.
2. Kelton JG, Hamid C, Aker S, Blajchman MA. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood. 1982;59:980-985.
3. Dunstan RA, Simpson MB, Knowles RW, Rosse WF. The origin of ABH antigens on human platelets. Blood. 1985;65:615-619.
4. Issitt PD, Anstee DJ. The ABO and H blood group system. Applied Blood Group Serology. 4th ed. Durham, NC: Montgomery Scientific Publications; 1998:175-246.
5. Cooling LL, Kelly K, Barton J, Hwang D, Koerner TA, Olson JD. Determinants of ABH expression on human blood platelets. Blood. 2005;105:3356-3364.
6. Duquesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood. 1979;54:595-599.
7. Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood. 1987;70:23-30.
8. Heal JM, Rowe JM, McMican A, Masel D, Finke C, Blumberg N. The role of ABO matching in platelet transfusion. Eur J Haematol. 1993;50:110-117.
9. Lee EJ, Schiffer CA. ABO compatibility can influence the results of platelet transfusion: results of a randomized trial. Transfusion. 1989;29:384-389.
10. Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol. 1990;75:408-413.
11. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy. Transfusion. 2004;44:805-808.
12. Pietersz RNI, Engelfriet CP, Reesink HW. International Forum: Transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:207-221.
13. Consensus conference. Platelet transfusion therapy. JAMA. 1987;257:1777-1780.
14. Standards for Blood Banks and Transfusion Services, Standard 5.14.4. 23rd ed. Bethesda, Md: AABB; 2004.
15. Commission on Laboratory Accreditation. Transfusion Medicine Checklist, TRM.40700 and TRM.40740. Laboratory Accreditation Program. Northfield, Ill: College of American Pathologists; December 2004.
16. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion. 2000;40:902-906.
17. Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO and Rh(D) incompatibility. Transfus Med Rev. 2003;17:57-68.
18. Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titer iso-agglutinins. Br Med J (Clin Res Ed). 1942;i:659-664.
19. Ebert RV, Emerson CP. A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible iso-agglutinins. J Clin Invest. 1946;25:627-638.
20. Tisdall LH, Garland DM, Szanto PB, Hand AM, Bonnett JC. The effects of the transfusion of group O blood of high iso-agglutinin titer into recipients of other blood groups. Am J Clin Pathol. 1946;16:193-206.
21. Ervin DM, Christian RM, Young LE. Dangerous universal donors, II. further observations on in vivo and in vitro behavior of isoantibodies of immune type present in group O blood. Blood. 1950;5:553-567.
22. Crawford H, Falconer H, Cutbush M, Mollison PL. Formation of immune A iso-antibodies, with special reference to heterogenetic stimuli. Lancet. 1952;2:219-223.
23. Gardner JM, Tovey GH. Potentially dangerous group-O blood. Lancet. 1954;266:1001-1004.
24. Grove-Rasmussen M. Selection of "safe" group O blood. Transfusion. 1966;6:331-335.
25. Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion. 1998;38:51-55.
26. Fauzie D, Shirey RS, Thoman S, Bensen-Kennedy D, King KE. The risk of hemolytic transfusion reactions due to passively-acquired ABO antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions [abstract]. Transfusion. 2004;44(suppl):36A.
27. Shanwell A, Ringden O, Wiechel B, Rumin S, Akerblom O. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients. Vox Sang. 1991;60:23-27.
28. Benjamin RJ, Antin JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion. 1999;39:1273-1274.
29. Lapierre V, Mahe C, Auperin A, et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation. 2005;80:314-319.
30. Heal JM, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol. 1994;45:189-190.
31. Blumberg N, Heal JM, Hicks GL Jr, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion. 2001;41:790-793.
32. Lin Y, Callum JL, Coovadia AS, Murphy PM. Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients. Transfusion. 2002;42:166-172.
33. Lundberg WB, McGinniss MH. Hemolytic transfusion reaction due to anti-A. Transfusion. 1975;15:1-9.
34. Zoes C, Dube VE, Miller HJ, Vye MV. Anti-A1 in the plasma of platelet concentrates causing a hemolytic reaction. Transfusion. 1977;17:29-32.
35. McLeod BC, Sassetti RJ, Weens JH, Vaithianathan T. Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol. 1982;28:193-196.
36. Siber GR, Ambrosino DM, Gorgone BC. Blood-group-A-like substance in a preparation of pneumococcal vaccine. Ann Intern Med. 1982;96:580-586.
37. Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletapheresis concentrate. Transfusion. 1984;24:413-414.
38. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion. 1985;25:60-62.
39. Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. CMAJ. 1988;138:523-524.
40. Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haematol. 1989;11:237-240.
41. Murphy MF, Hook S, Waters AH, et al. Acute haemolysis after ABO-incompatible platelet transfusions. Lancet. 1990;335:974-975.
42. Chow MP, Yung CH, Hu HY, Tzeng CH. Hemolysis after ABO-incompatible platelet transfusions. Zhonghua Yi Xue Za Zhi (Taipei). 1991;48:131-134.
43. The Serious Hazards of Transfusion Steering Group. Serious Hazards of Transfusion (SHOT) 1998-1999 Annual Report (UK). Manchester, United Kingdom: SHOT Office; 2000. Available at: http://www.shot.demon.co.uk/ shot%20report%201998-99.html. Accessed March 11, 2006.
44. Duguid JK, Minards J, Bolton-Maggs PH. Lesson of the week: incompatible plasma transfusions and haemolysis in children. BMJ. 1999;318:176-177.
45. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products: an underrecognized transfusion reaction. Am J Clin Pathol. 1999;111:202-206.
46. Valbonesi M, De Luigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs. 2000;23:642-646.
47. The Serious Hazards of Transfusion Steering Group. Serious Hazards of Transfusion (SHOT) 2000-2001 Annual Report (UK). Manchester, United Kingdom: SHOT Office; 2002. Available at: http://www.shotuk.org/shot%20report%2000-01. pdf. Accessed March 10, 2006.
48. The Serious Hazards of Transfusion Steering Group. Serious Hazards of Transfusion (SHOT) 2003 Annual Report (UK). Manchester, United Kingdom: SHOT Office; 2004. Available at: http://www.shotuk.org/shot%20report%202003.pdf. Accessed March 10, 2006.
49. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher. 2005;20:225-229.
50. Reinhardt P, Wiesneth M, Schrezenmeier H, Seifried E. International Forum: Transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:212-213.
51. Novotny VMJ, Brand A. International Forum: Transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:215-216.
52. MacLennan S. International Forum: Transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:218-219.